Rare Germline Variants in ATM Are Associated with Chronic Lymphocytic Leukemia

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2017 Jun 28

PMID 28652578

Citations 16

Authors

G Tiao

M R Improgo

S Kasar

W Poh

A Kamburov

D-A Landau

E Tausch

A Taylor-Weiner

C Cibulskis

S Bahl

S M Fernandes

K Hoang

E Rheinbay

H T Kim

J Bahlo

S Robrecht

K Fischer

M Hallek

S Gabriel

E S Lander

S Stilgenbauer

C J Wu

A Kiezun

G Getz

J R Brown

Affiliations

Soon will be listed here.

Citing Articles

Germline Variant Spectrum in Southern Italian High-Risk Hereditary Breast Cancer Patients: Insights from Multi-Gene Panel Testing.

Rocca V, Lo Feudo E, Dinatolo F, Lavano S, Bilotta A, Amato R Curr Issues Mol Biol. 2024; 46(11):13003-13020.

PMID: 39590369 PMC: 11592649. DOI: 10.3390/cimb46110775.

Clinical Risks for Chronic Lymphocytic Leukemia.

Brown J J Natl Compr Canc Netw. 2024; 22(3).

PMID: 38626793 PMC: 11800170. DOI: 10.6004/jnccn.2024.7020.

Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era.

Sanchez Suarez M, Roldan A, Alarcon-Payer C, Rodriguez-Gil M, Poquet-Jornet J, Puerta Puerta J Pharmaceutics. 2024; 16(1).

PMID: 38258066 PMC: 10818903. DOI: 10.3390/pharmaceutics16010055.

Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome.

Arai H, Matsui H, Chi S, Utsu Y, Masuda S, Aotsuka N Int J Mol Sci. 2024; 25(1).

PMID: 38203823 PMC: 10779750. DOI: 10.3390/ijms25010652.

Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma.

Pastorino L, Dalmasso B, Allavena E, Vanni I, Ugolini F, Baroni G Int J Mol Sci. 2022; 23(24).

PMID: 36555667 PMC: 9786167. DOI: 10.3390/ijms232416027.

References

Tavtigian S, Oefner P, Babikyan D, Hartmann A, Healey S, Le Calvez-Kelm F . Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am J Hum Genet. 2009; 85(4):427-46. PMC: 2756555. DOI: 10.1016/j.ajhg.2009.08.018. View

Puente X, Pinyol M, Quesada V, Conde L, Ordonez G, Villamor N . Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 2011; 475(7354):101-5. PMC: 3322590. DOI: 10.1038/nature10113. View

Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd P . Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet. 1999; 353(9146):26-9. DOI: 10.1016/S0140-6736(98)10117-4. View

Wang L, Lawrence M, Wan Y, Stojanov P, Sougnez C, Stevenson K . SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med. 2011; 365(26):2497-506. PMC: 3685413. DOI: 10.1056/NEJMoa1109016. View

Goldin L, Pfeiffer R, Li X, Hemminki K . Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood. 2004; 104(6):1850-4. DOI: 10.1182/blood-2004-01-0341. View

Landau D, Carter S, Stojanov P, McKenna A, Stevenson K, Lawrence M . Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell. 2013; 152(4):714-26. PMC: 3575604. DOI: 10.1016/j.cell.2013.01.019. View

Lahdesmaki A, Kimby E, Duke V, Foroni L, Hammarstrom L . ATM mutations in B-cell chronic lymphocytic leukemia. Haematologica. 2004; 89(1):109-10. View

Young E, Feng B, Stark A, Damiola F, Durand G, Forey N . Multigene testing of moderate-risk genes: be mindful of the missense. J Med Genet. 2016; 53(6):366-76. PMC: 4893078. DOI: 10.1136/jmedgenet-2015-103398. View

Skol A, Scott L, Abecasis G, Boehnke M . Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet. 2006; 38(2):209-13. DOI: 10.1038/ng1706. View

10.

Adzhubei I, Schmidt S, Peshkin L, Ramensky V, Gerasimova A, Bork P . A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7(4):248-9. PMC: 2855889. DOI: 10.1038/nmeth0410-248. View

11.

Jhuraney A, Velkova A, Johnson R, Kessing B, Carvalho R, Whiley P . BRCA1 Circos: a visualisation resource for functional analysis of missense variants. J Med Genet. 2015; 52(4):224-30. PMC: 4392196. DOI: 10.1136/jmedgenet-2014-102766. View

12.

La Paglia L, Lauge A, Weber J, Champ J, Cavaciuti E, Russo A . ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy. Breast Cancer Res Treat. 2009; 119(2):443-52. DOI: 10.1007/s10549-009-0396-z. View

13.

Boultwood J . Ataxia telangiectasia gene mutations in leukaemia and lymphoma. J Clin Pathol. 2001; 54(7):512-6. PMC: 1731462. DOI: 10.1136/jcp.54.7.512. View

14.

Rudd M, Sellick G, Webb E, Catovsky D, Houlston R . Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood. 2006; 108(2):638-44. DOI: 10.1182/blood-2005-12-5022. View

15.

Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L . Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2001; 343(26):1910-6. DOI: 10.1056/NEJM200012283432602. View